$COEP
Coeptis Therapeutics Holdings, Inc.

2023 Q1 Form 10-K Financial Statement

#000168316823001850 Filed on March 29, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change -100.0%
Gross Profit Margin
Selling, General & Admin $6.424M $34.18M
YoY Change -59.13% 142.02%
% of Gross Profit
Research & Development $25.74K $20.89K
YoY Change
% of Gross Profit
Depreciation & Amortization $250.3K $1.001M $1.001M
YoY Change -0.01% 124.42% 123.82%
% of Gross Profit
Operating Expenses $6.449M $34.20M $34.20M
YoY Change 1436.37% 11936.59% 4919.08%
Operating Profit -$6.449M -$34.20M
YoY Change -58.96% 143.46%
Interest Expense $31.42K $218.4K
YoY Change 365.44% 2781.42%
% of Operating Profit
Other Income/Expense, Net -$1.419M -$3.378M -$3.378M
YoY Change -139.44% 261.51% -121.24%
Pretax Income -$7.868M -$37.57M -$37.57M
YoY Change -347.06% 2988.28% -346.72%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.868M -$37.57M -$37.57M
YoY Change -347.06% 2988.28% -346.72%
Net Earnings / Revenue
Basic Earnings Per Share -$0.39 -$2.63
Diluted Earnings Per Share -$0.39 -$2.63 -$2.63
COMMON SHARES
Basic Shares Outstanding 20.44M shares 5.116M shares 14.30M shares
Diluted Shares Outstanding 20.08M shares 14.30M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.107M $3.791M $3.791M
YoY Change 1166.35% 837.63% 837.63%
Cash & Equivalents $2.107M $3.791M
Short-Term Investments
Other Short-Term Assets $169.2K $142.4K $142.4K
YoY Change 235.22% 1609.0% 1609.0%
Inventory
Prepaid Expenses $169.1K $142.4K
Receivables $0.00 $8.075K $8.080K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.276M $3.942M $3.942M
YoY Change 949.66% 855.15% 855.15%
LONG-TERM ASSETS
Property, Plant & Equipment $12.23K $12.54K $71.46K
YoY Change -87.86% -9.94% 124.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.605M $3.903M $3.903M
YoY Change
Total Long-Term Assets $3.666M $3.974M $3.974M
YoY Change -95.16% -94.75% -94.75%
TOTAL ASSETS
Total Short-Term Assets $2.276M $3.942M $3.942M
Total Long-Term Assets $3.666M $3.974M $3.974M
Total Assets $5.942M $7.916M $7.916M
YoY Change -92.18% -89.61% -89.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $242.5K $99.02K $99.02K
YoY Change -33.37% -29.24% -29.24%
Accrued Expenses $205.0K $182.0K $223.6K
YoY Change -30.11% -8.6% 4.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.500M $1.500M $1.500M
YoY Change -30.78% -37.94% -37.94%
Total Short-Term Liabilities $1.979M $1.823M $1.823M
YoY Change 443.91% 1202.53% 1202.54%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $150.0K $150.0K
YoY Change
Other Long-Term Liabilities $2.527M $1.140M $1.140M
YoY Change -26.73% -83.83% -83.83%
Total Long-Term Liabilities $2.677M $1.290M $1.290M
YoY Change -22.38% -81.7% -81.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.979M $1.823M $1.823M
Total Long-Term Liabilities $2.677M $1.290M $1.290M
Total Liabilities $4.656M $3.112M $3.112M
YoY Change 22.11% -56.69% -56.69%
SHAREHOLDERS EQUITY
Retained Earnings -$73.61M -$65.74M
YoY Change 866.87%
Common Stock $2.094K $1.957K
YoY Change -92.17%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $0.00
YoY Change -100.0%
Treasury Stock Shares
Shareholders Equity $1.286M $4.803M $4.803M
YoY Change
Total Liabilities & Shareholders Equity $5.942M $7.916M $7.916M
YoY Change -92.18% -89.61% -89.61%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$7.868M -$37.57M -$37.57M
YoY Change -347.06% 2988.28% -346.72%
Depreciation, Depletion And Amortization $250.3K $1.001M $1.001M
YoY Change -0.01% 124.42% 123.82%
Cash From Operating Activities -$1.684M -$3.311M -$3.876M
YoY Change 607.85% 1736.75% 670.78%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$42.69M $0.00
YoY Change
Cash From Investing Activities $0.00 -$42.69M $0.00
YoY Change -1497.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.271M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 48.01M $5.488M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -$1.684M -3.311M -$3.876M
Cash From Investing Activities $0.00 -42.69M $0.00
Cash From Financing Activities $0.00 48.01M $5.488M
Net Change In Cash -$1.684M 2.002M $1.612M
YoY Change 607.85% -1210.58%
FREE CASH FLOW
Cash From Operating Activities -$1.684M -$3.311M -$3.876M
Capital Expenditures $0.00
Free Cash Flow -$1.684M
YoY Change 607.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001759186
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 coep Retirement Of Shares
RetirementOfShares
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39669
CY2022 dei Entity Registrant Name
EntityRegistrantName
Coeptis Therapeutics Holdings, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1465952
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
105 Bradford Rd
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 420
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Wexford
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15090
CY2022 dei City Area Code
CityAreaCode
724
CY2022 dei Local Phone Number
LocalPhoneNumber
934-6467
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
49998259 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20441036 shares
CY2022 dei Auditor Firm
AuditorFirmId
76
CY2022 dei Auditor Name
AuditorName
Turner, Stone & Company, LLP
CY2022 dei Auditor Location
AuditorLocation
Dallas, Texas
CY2022Q4 us-gaap Cash
Cash
3791302 usd
CY2021Q4 us-gaap Cash
Cash
2179558 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8075 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
142356 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3941733 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2179558 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25237 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25237 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12695 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11311 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12542 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13926 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
348333 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
0 usd
CY2022Q4 us-gaap Finite Lived Contractual Rights Gross
FiniteLivedContractualRightsGross
3554167 usd
CY2021Q4 us-gaap Finite Lived Contractual Rights Gross
FiniteLivedContractualRightsGross
4554167 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58914 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17925 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
3961414 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
4572092 usd
CY2022Q4 us-gaap Assets
Assets
7915689 usd
CY2021Q4 us-gaap Assets
Assets
6765576 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
99021 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
134092 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
181998 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
199126 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1500000 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2417000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41618 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14724 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1822637 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2764942 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
150000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1650000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1125000 usd
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14723 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1289723 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1650000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3112360 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4414942 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19566839 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19566839 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12492050 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12381287 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1957 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1196 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
70541095 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30146728 usd
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
110762 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
110762 shares
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
-0 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
247165 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65739723 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27550126 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4803329 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2350634 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7915689 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6765576 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
75000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Gross Profit
GrossProfit
0 usd
CY2021 us-gaap Gross Profit
GrossProfit
75000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20887 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34166746 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14118014 usd
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8331 usd
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2918 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
34195964 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
14120932 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-34195964 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-14045932 usd
CY2022 us-gaap Royalty Expense
RoyaltyExpense
90000 usd
CY2021 us-gaap Royalty Expense
RoyaltyExpense
413124 usd
CY2022 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
0 usd
CY2021 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
1000000 usd
CY2022 us-gaap Other Income
OtherIncome
98701 usd
CY2021 us-gaap Other Income
OtherIncome
198910 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3393542 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2000 usd
CY2022 coep Gain On Write Down Of Liabilities
GainOnWriteDownOfLiabilities
225000 usd
CY2021 coep Gain On Write Down Of Liabilities
GainOnWriteDownOfLiabilities
0 usd
CY2022 us-gaap Interest Expense
InterestExpense
218412 usd
CY2021 us-gaap Interest Expense
InterestExpense
187133 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3378253 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
596653 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37574217 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13449280 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-37574217 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13449280 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.63
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.63
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.23
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14295678 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14295678 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10914574 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10914574 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5143342 usd
CY2021 coep Recapitalization
Recapitalization
-50896 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
247165 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10136500 usd
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2757501 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
5497132 usd
CY2021 coep Shares Issued Through Conversion Of Debt
SharesIssuedThroughConversionOfDebt
1040999 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1897585 usd
CY2021 coep Shares Surrendered In Payment Of Debt
SharesSurrenderedInPaymentOfDebt
-88400 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13449280 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2350634 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3271486 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4983500 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5247649 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
23730298 usd
CY2022 coep Warrants Issued For Extinguishment Of Debt
WarrantsIssuedForExtinguishmentOfDebt
3408559 usd
CY2022 coep Merger
Merger
-614580 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-37574217 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4803329 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-37574217 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13449280 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1001384 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
447413 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-0 usd
CY2021 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
160095 usd
CY2022 coep Loss On Termination Of Licensing Agreement In Exchange For Convertible Debt
LossOnTerminationOfLicensingAgreementInExchangeForConvertibleDebt
0 usd
CY2021 coep Loss On Termination Of Licensing Agreement In Exchange For Convertible Debt
LossOnTerminationOfLicensingAgreementInExchangeForConvertibleDebt
1500000 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
4983500 usd
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2757501 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1897585 usd
CY2022 coep Warrants Issued For Services
WarrantsIssuedForServices
23730298 usd
CY2021 coep Warrants Issued For Services
WarrantsIssuedForServices
5497132 usd
CY2022 coep Warrants Issued For Extinguishment Of Debt Cash Flow
WarrantsIssuedForExtinguishmentOfDebtCashFlow
3408559 usd
CY2021 coep Warrants Issued For Extinguishment Of Debt Cash Flow
WarrantsIssuedForExtinguishmentOfDebtCashFlow
0 usd
CY2022 coep Derivative Liability Warrants
DerivativeLiabilityWarrants
1125000 usd
CY2021 coep Derivative Liability Warrants
DerivativeLiabilityWarrants
0 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8075 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21786 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
628 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1317 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-0 usd
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
490689 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-0 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-35071 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1578145 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-17128 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-424020 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1000000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3875811 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4489440 usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
-0 usd
CY2021 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1750000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1750000 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
77595 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2417000 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1700000 usd
CY2022 coep Cash Paid For Debt As Part Of Merger Rec
CashPaidForDebtAsPartOfMergerRec
614580 usd
CY2021 coep Cash Paid For Debt As Part Of Merger Rec
CashPaidForDebtAsPartOfMergerRec
50897 usd
CY2022 coep Stocks Repurchased During Period Value
StocksRepurchasedDuringPeriodValue
-0 usd
CY2021 coep Stocks Repurchased During Period Value
StocksRepurchasedDuringPeriodValue
247165 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3271486 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10136500 usd
CY2022 coep Shares Issued For Cash For Conversion Warrants
SharesIssuedForCashForConversionWarrants
5247649 usd
CY2021 coep Shares Issued For Cash For Conversion Warrants
SharesIssuedForCashForConversionWarrants
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5487555 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8216033 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1611744 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1976593 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2179558 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202965 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3791302 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2179558 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1384 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2546 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20887 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zKXoJd3yxD17" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_864_zNS6pWQ9slz7">Use of Estimates</span></b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58914 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17925 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41618 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14724 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14723 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65739723 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
250000 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1500000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1420 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
148580 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
150000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19566839 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19566839 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12492050 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12381287 shares
CY2022 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
3271487 usd
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
10136500 usd
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
45000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
45000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
18750 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
63750 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7409 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
56341 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58914 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41618 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14723 usd
CY2022Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
0 usd
CY2021Q4 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
0 usd
CY2022Q4 coep Royalty Advance
RoyaltyAdvance
0 usd
CY2021Q4 coep Royalty Advance
RoyaltyAdvance
0 usd
CY2022Q3 us-gaap Taxes And Licenses
TaxesAndLicenses
75000 usd
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11648000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
7130000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11648000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7130000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 coep Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate1
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate1
7906850 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 coep Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate1
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate1
4830000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3765167 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.100 pure
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2300000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.100 pure
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-24017 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.002 pure
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-0 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11648000 usd
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.308 pure
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
7130000 usd
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.310 pure
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
59000000 usd

Files In Submission

Name View Source Status
0001683168-23-001850-index-headers.html Edgar Link pending
0001683168-23-001850-index.html Edgar Link pending
0001683168-23-001850.txt Edgar Link pending
0001683168-23-001850-xbrl.zip Edgar Link pending
coep-20221231.xsd Edgar Link pending
coeptis_ex2101.htm Edgar Link pending
coeptis_ex3101.htm Edgar Link pending
coeptis_ex3102.htm Edgar Link pending
coeptis_ex3201.htm Edgar Link pending
coeptis_ex3202.htm Edgar Link pending
coeptis_i10k-123122.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
coep-20221231_lab.xml Edgar Link unprocessable
coep-20221231_pre.xml Edgar Link unprocessable
coep-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
coeptis_i10k-123122_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending
coep-20221231_cal.xml Edgar Link unprocessable